Home / Unlabelled / FDA authorizes Roche drug for severely ill COVID-19 patients

FDA authorizes Roche drug for severely ill COVID-19 patients

The Guardian Express Saturday, June 26, 2021

FDA authorizes Roche drug for severely ill COVID-19 patients

The Food and Drug Administration granted emergency approval to Roche’s Actemra (tocilizumab) to boost outcomes among hospitalized COVID-19 patients receiving oxygen and steroid medications.

via FOX NEWS https://ift.tt/3wXlK3U

No comments

Subscribe to: Post Comments ( Atom )